HACD4
Very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase 4
Also known as: Em:AL662879.1, HACD4_HUMAN, PTPLAD2
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q5VWC8
- Gene
- HACD4
- Ensembl
- ENSG00000188921
- Chromosome
- 9
- Canonical length
- 232 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted membrane proteins
OverviewNCBI Gene
Enables enzyme binding activity and very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase activity. Involved in fatty acid elongation and very long-chain fatty acid biosynthetic process. Located in endoplasmic reticulum. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
232 residues, UniProt reviewed canonical sequence.
>Q5VWC8|HACD4
1 MGPLALPAWL QPRYRKNAYL FIYYLIQFCG HSWIFTNMTV RFFSFGKDSM VDTFYAIGLV
61 MRLCQSVSLL ELLHIYVGIE SNHLLPRFLQ LTERIIILFV VITSQEEVQE KYVVCVLFVF
121 WNLLDMVRYT YSMLSVIGIS YAVLTWLSQT LWMPIYPLCV LAEAFAIYQS LPYFESFGTY
181 STKLPFDLSI YFPYVLKIYL MMLFIGMYFT YSHLYSERRD ILGIFPIKKK KMLocalizationUniProt · AlphaFold · HPA
Whether an antibody against HACD4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 6
- Mean surface accessibility (rSASA)
- 0.31
- Highest tissue expression
- 11 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 11 nTPM
- lung: 7.8 nTPM
- placenta: 6 nTPM
- cervix: 4.9 nTPM
- thymus: 4.8 nTPM
- ovary: 4.3 nTPM
Single-cell type
- platelets: 500 nCPM
- megakaryocytes: 173 nCPM
- neutrophils: 139 nCPM
- respiratory ciliated cells: 107 nCPM
- neutrophil progenitors: 104 nCPM
- hofbauer cells: 101 nCPM
Immune cell
- basophil: 21 nTPM
- eosinophil: 14 nTPM
- neutrophil: 12 nTPM
- non-classical monocyte: 11 nTPM
- intermediate monocyte: 11 nTPM
- myeloid DC: 10 nTPM
Brain region
- choroid plexus: 9.5 nTPM
- cerebral cortex: 8.7 nTPM
- cerebellum: 7.6 nTPM
- white matter: 6.7 nTPM
- amygdala: 6.3 nTPM
- basal ganglia: 6.3 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.19
- gnomAD pLI
- 0
- DepMap mean gene effect
- 0.21
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- fatty acid elongation
- sphingolipid biosynthetic process
- very long-chain fatty acid biosynthetic process
Molecular functions
- 3-hydroxyacyl-CoA dehydratase activity
- enzyme binding
- very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads HACD4 as an antibody target. Whether an autoantibody or antibody against HACD4 could matter depends on whether native HACD4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
HACD4 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label HACD4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...